Aura Biosciences (AURA) Operating Income Growth (5y) (2025 - 2026)

Aura Biosciences (AURA) Operating Income Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,132.22 Bn	67,131.94 Bn	-
2	Nanobiotix	1,911.83 Bn	1,911.77 Bn	-
3	Akari Therapeutics	973.81 Bn	973.81 Bn	-
4	BeOne Medicines	471.45 Bn	466.66 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.00 Bn	114.75 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.99 Bn	61.23 Bn	3.31 Bn
7	Belite Bio	62.68 Bn	62.68 Bn	-
8	Argenx Se	55.86 Bn	50.67 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.47 Bn	34.46 Bn	959.66 Mn
10	Aura Biosciences	484.27 Mn	399.48 Mn	-

Download Data